Literature DB >> 31820484

Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease.

Kavya Jash1, Piyush Gondaliya1, Prathibha Kirave1, Bhagyashri Kulkarni1, Aditya Sunkaria1, Kiran Kalia1.   

Abstract

Diabetes mellitus (DM) is a gradually rising metabolic disease which is currently affecting millions of people worldwide. Diabetes is associated with various complications like nephropathy, neuropathy, retinopathy, diabetic foot, cognitive impairment, and many more. Evidence suggests that cognitive dysfunction is a rising complication of diabetes which adversely affects the brain of patients suffering from diabetes. Age-related memory impairment is a complication having its major effect on people suffering from diabetes and Alzheimer's. Patients suffering from diabetes are at two times higher risk of developing cognitive dysfunction as compared with normal individuals. Multiple factors which are involved in diabetes related complications are found to play a role in the development of neurodegeneration in Alzheimer's. The problem of insulin deficiency and insulin resistance is well reported in diabetes but there are many studies which suggest dysregulation of insulin levels as a reason behind the development of Alzheimer's. As the link between diabetes and Alzheimer disease (AD) is deepening, there is a need to understand the plausible tie-ins between the two. Emerging role of major factors like insulin imbalance, advanced glycation end products and micro-RNA's involved in diabetes and Alzheimer's have been discussed here. This review helps in understanding the plausible mechanism underlying the pathophysiology of amyloid beta (Aβ) plaque formation and tau hyperphosphorylation as well provides information about studies carried out in this area of research. The final thought is to enhance the scientific knowledge on this correlation and develop future therapeutics to treat the same.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's; Aβ plaque; cognitive dysfunction; diabetes; insulin

Mesh:

Substances:

Year:  2019        PMID: 31820484     DOI: 10.1002/ddr.21579

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  15 in total

1.  Neuroprotective Effects of 2-Substituted 1, 3-Selenazole Amide Derivatives on Amyloid-Beta-Induced Toxicity in a Transgenic Caenorhabditis Elegans Model of Alzheimer's Disease.

Authors:  Huiying Wang; Yuandong Yue; Haifeng Zhao; Hao Wu; Kai Jiang; Shuang Li; Meihua Zhao; Feng Lin
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

Review 2.  Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights.

Authors:  Sarvin Sanaie; Saba Nikanfar; Zahra Yousefi Kalekhane; Akbar Azizi-Zeinalhajlou; Saeed Sadigh-Eteghad; Mostafa Araj-Khodaei; Mohammad Hossein Ayati; Sasan Andalib
Journal:  Metab Brain Dis       Date:  2022-08-20       Impact factor: 3.655

3.  Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B.

Authors:  Athika Rampadarath; Fatai Oladunni Balogun; Charlene Pillay; Saheed Sabiu
Journal:  J Diabetes Res       Date:  2022-06-24       Impact factor: 4.061

4.  Exercise as a Therapeutic Intervention in Gestational Diabetes Mellitus.

Authors:  Konstantina Dipla; Andreas Zafeiridis; Gesthimani Mintziori; Afroditi K Boutou; Dimitrios G Goulis; Anthony C Hackney
Journal:  Endocrines       Date:  2021-03-26

5.  A Study of the Protective Effect of Bushen Huoxue Prescription on Cerebral Microvascular Endothelia Based on Proteomics and Bioinformatics.

Authors:  Shao-Yang Zhao; Huan-Huan Zhao; Yi-Ming Li; Bao-Hua Wang; Sai-Mei Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-06       Impact factor: 2.629

6.  Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis.

Authors:  Zhaoliang Zhu; Peng Duan; Huping Song; Rongle Zhou; Tao Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Effect of Acupuncture on Cognitive Function of Insomnia Patients Compared with Drugs: A Protocol for Meta-analysis and Systematic Review.

Authors:  Shan Qin; Jing Jiang; Wen-Zhong Wu; Xiao-Qiu Wang; Han-Qing Xi; Qin-Qin Fang; Bin Xu; Cheng-Yong Liu
Journal:  Behav Neurol       Date:  2021-09-11       Impact factor: 3.342

Review 8.  Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause.

Authors:  Valentina Echeverria; Florencia Echeverria; George E Barreto; Javier Echeverría; Cristhian Mendoza
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

Review 9.  Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease.

Authors:  Alex Cleber Improta-Caria; Carolina Kymie Vasques Nonaka; Bruno Raphael Ribeiro Cavalcante; Ricardo Augusto Leoni De Sousa; Roque Aras Júnior; Bruno Solano de Freitas Souza
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

Review 10.  Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging.

Authors:  Meredith Hay; Carol Barnes; Matt Huentelman; Roberta Brinton; Lee Ryan
Journal:  Curr Hypertens Rep       Date:  2020-09-03       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.